Acromegaly Community Patient-Focused Drug Development Meeting

April 28th, 2020

This Patient-Focused Drug Development meeting is designed as a convergence of critical FDA officials, acromegaly patients, pharmaceutical companies, and other relevant stakeholders for an important day of conversation about the future of acromegaly treatment.

This event will primarily feature patient testimony through panels and audience feedback related to the day to day challenges of living with this rare disease, as well as the goals that a future therapy for acromegaly should aim to reach.

To register for this meeting, click here.